What is the difference between metoprolol tartrate and succinate?

They are the same drug in different release formulations. Tartrate is immediate-release, works within an hour, lasts about 12 hours, and is taken twice daily. Succinate is extended-release, covers roughly 24 hours from a single dose, and holds a steadier level without the peaks and troughs. The salt name itself has no clinical effect and simply distinguishes the 2 products.

How do I switch from metoprolol tartrate to succinate?

The total daily dose stays the same. If you take 25 mg of tartrate twice daily, that is 50 mg once daily of succinate. Take your last tartrate dose at dinner and begin the succinate the next morning, about 12 hours later, so coverage stays continuous. Monitor heart rate and blood pressure for a week or 2 afterward, since a small adjustment is occasionally needed once the level evens out.

Can I stop taking metoprolol suddenly?

No. Abrupt discontinuation after regular use can cause rebound tachycardia, a rise in blood pressure, and in people with coronary artery disease, angina or worse. Coming off requires a gradual taper over a couple of weeks with guidance. This applies to both formulations.

What is the difference between metoprolol tartrate and succinate?

They are the same drug in different release formulations. Tartrate is immediate-release, works within an hour, lasts about 12 hours, and is taken twice daily. Succinate is extended-release, covers roughly 24 hours from a single dose, and holds a steadier level without the peaks and troughs. The salt name itself has no clinical effect and simply distinguishes the 2 products.

How do I switch from metoprolol tartrate to succinate?

The total daily dose stays the same. If you take 25 mg of tartrate twice daily, that is 50 mg once daily of succinate. Take your last tartrate dose at dinner and begin the succinate the next morning, about 12 hours later, so coverage stays continuous. Monitor heart rate and blood pressure for a week or 2 afterward, since a small adjustment is occasionally needed once the level evens out.

Can I stop taking metoprolol suddenly?

No. Abrupt discontinuation after regular use can cause rebound tachycardia, a rise in blood pressure, and in people with coronary artery disease, angina or worse. Coming off requires a gradual taper over a couple of weeks with guidance. This applies to both formulations.

Metoprolol Tartrate vs Succinate: Which Form and Why It Changes

TL;DR30-second take

Metoprolol tartrate is short-acting and taken twice daily, which makes it the better tool for finding the right dose quickly because you see the effect and can adjust within days. Metoprolol succinate is extended-release, covers a full 24 hours from one dose, and carries the stronger evidence for long-term cardiac protection. The usual sequence is tartrate to establish the dose, then a switch to succinate at the same total daily amount. Keeping a few tartrate tablets afterward for the days heart rate predictably climbs is a deliberate strategy rather than a leftover.

TL;DR: These are the same medicine in 2 different wrappers. Tartrate is the short one. It wears off in half a day, so you take it twice, and its advantage is that you feel the effect fast, which makes it the right choice while your doctor is still figuring out your dose. Succinate is the long one. It releases slowly and covers a full 24 hours from a single morning pill, and it is the version with the better evidence for protecting your heart over years. So most people should start on tartrate and switch to succinate once the dose is settled. The switch is simple: add up your daily tartrate, take that same total as one succinate in the morning, starting the day after your last tartrate dose. Ask whether you should keep a few tartrate tablets on hand for days when you know your heart rate will climb, like when you are sick or using a nebulizer or prepping for a colonoscopy. Never stop either one suddenly.

What is the difference between the 2 forms?

The drug is identical. What differs is how fast it leaves.

Metoprolol tartrate, sold as Lopressor, is immediate-release. It is absorbed quickly, works within an hour, and is largely gone in about 12 hours, which is why it is prescribed twice a day. The consequence of that short life is a peak and a trough: more effect a couple of hours after each dose and less effect before the next one.

Metoprolol succinate, sold as Toprol-XL, is extended-release. The tablet releases the drug gradually so a single dose covers roughly 24 hours at a steadier level, without the same swing between peak and trough.

The salt attached to the name, tartrate or succinate, is doing nothing clinically. It is a manufacturing detail that happens to be the easiest way to tell the 2 products apart on a label.

Why start with the short-acting one?

Because finding your dose is a different problem from staying on it.

When metoprolol is being started, nobody knows yet what dose you need. The right amount depends on your resting heart rate, your blood pressure, how much of your symptom it controls, and how you tolerate it. Tartrate gives you that information quickly, since you feel the effect within hours and a dose change shows its result within a day or 2. That makes the titration fast and lets an adjustment happen on a short leash.

Trying to do the same work with succinate is slower. The steady release that makes it good for maintenance also means changes take longer to show themselves, and you end up waiting through each step. Nothing is wrong with starting on succinate, and the reason we usually do not is time.

Why switch to the long-acting one afterward?

Two reasons, and the second is the one that matters more.

The first is convenience, and it is not trivial. One pill a day gets taken far more reliably than 2, and steady coverage means you are not drifting into a trough every evening while you wait for the next dose.

The second is the evidence. The large trials establishing that a beta blocker improves survival and reduces hospitalization in heart failure were done with the extended-release succinate formulation, and that is the version guidelines point to for long-term cardiac protection. The immediate-release form controls heart rate perfectly well, and it does not carry the same body of outcome data behind it. When somebody is going to be on this medication for years, that difference is worth having on your side.

So the sequence that makes sense for most people is tartrate to find the dose, then succinate to live on.

How does the switch work?

Straightforwardly, and the arithmetic is the same total daily amount.

If you take 25 mg of tartrate twice a day, that is 50 mg daily, and you move to 50 mg of succinate once daily. The practical timing is to take your last tartrate dose at dinner and start the succinate the following morning, roughly 12 hours later, which keeps coverage continuous without doubling up.

Expect it to feel slightly different rather than identical. Some people notice the sharper early effect of the tartrate is gone, which is the point, and others notice their evenings feel steadier for the same reason. Watch your heart rate and blood pressure for the first week or 2 after switching, since the dose that suited a peak-and-trough pattern occasionally needs a small adjustment once the level is even.

What is the pill-in-the-pocket approach?

Evidence-Based Treatment

Dr. Ash reviews the research - and applies it to your specific biology.

Book a Consultation

Keeping a small supply of the short-acting tartrate for the specific days you know your heart rate will climb.

Some of those climbs are predictable. Albuterol and other nebulized bronchodilators raise heart rate as a matter of pharmacology. Being acutely ill does it. Colonoscopy prep does it, through fluid shifts and dehydration over a long evening. For somebody who already deals with tachycardia, those are the days it becomes hardest to manage, and they are all scheduled or at least recognizable in advance.

The strategy is to keep a few tartrate tablets and take one when you can feel the rate climbing, on top of your daily succinate. It works because the short-acting form suits the job, arriving quickly and clearing before it stacks up, and because somebody whose resting heart rate is well controlled has room to give.

Two conditions make this safe. Your usual resting heart rate has to have enough margin, so this is not appropriate when you are already running low. And you need a number to act on rather than a feeling, which means checking your pulse before you take one rather than dosing off the sensation alone.

Ask for it explicitly, since it is often not offered. It is a small prescription that removes a recurring problem.

What should I watch out for?

A few things, and the first of them is important.

Do not stop abruptly. Stopping a beta blocker suddenly after regular use can produce rebound tachycardia, a rise in blood pressure, and in people with coronary disease, chest pain or worse. If it needs to come off, it comes off over a couple of weeks under guidance.

Asthma and airway disease. Metoprolol is beta-1 selective, meaning it acts mainly on the heart rather than the airways, which is why it is usable in many people with asthma when a non-selective beta blocker would not be. That selectivity is relative and falls at higher doses, so it is a conversation rather than a blanket yes or no, and worth revisiting if your breathing changes after a dose increase.

Low heart rate and lightheadedness. Standing up and feeling faint, unusual fatigue, or a resting pulse persistently below the 50s means the dose needs review rather than perseverance.

Interactions. Certain antidepressants that inhibit the CYP2D6 enzyme, including fluoxetine, paroxetine, and bupropion, raise metoprolol levels meaningfully. Tell whoever prescribes either one about the other.

Guidance from the Clinic

"People stay on the short-acting version for years because it was what got started in the beginning and nobody revisited it. Tartrate is the right tool for finding your dose and the wrong one for living on it, so once we know the number, moving to succinate gives you steadier coverage and the formulation with the outcome data behind it. Then I like leaving a few tartrate tablets in the cabinet for the days you can see coming, because a scheduled procedure or a nebulizer treatment is a predictable problem and it deserves a plan rather than a bad evening."

Key Takeaways

Tartrate and succinate are the same drug; only the release rate differs.
Tartrate is short-acting and taken twice daily, which makes dose-finding fast.
Succinate covers 24 hours from one dose and carries the stronger long-term outcome evidence.
The switch keeps the same total daily dose: 25 mg twice daily becomes 50 mg once daily.
Take the last tartrate dose at dinner and start succinate the next morning.
Keeping a few tartrate tablets for the days heart rate predictably climbs is a deliberate plan worth asking for.
Never stop a beta blocker abruptly, and tell prescribers about fluoxetine, paroxetine, or bupropion.

Skipped Heartbeats and PVCs - where a beta blocker fits among the drivers
Racing Heart When Standing (POTS) - the positional pattern
Understanding High Blood Pressure at Home - measuring properly between visits
Paying Cash for Care - pricing a generic across pharmacies before you fill it

Scientific References

MERIT-HF Study Group. "Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)." The Lancet. 1999;353(9169):2001-2007. PubMed
Wikstrand J, Hjalmarson A, Waagstein F, et al. "Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure." Journal of the American College of Cardiology. 2002;40(3):491-498. PubMed
Salpeter SR, Ormiston TM, Salpeter EE. "Cardioselective beta-blockers for reversible airway disease." Cochrane Database of Systematic Reviews. 2002;(4):CD002992. PubMed
Bijl MJ, Visser LE, van Schaik RHN, et al. "Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users." Clinical Pharmacology and Therapeutics. 2009;85(1):45-50. PubMed

Fishtown Medicine | Treatments

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

Neither is better for every purpose. Tartrate is better while the dose is being established, because its rapid effect lets adjustments happen within days. Succinate is better for long-term use, because once-daily dosing is taken more reliably and it is the formulation used in the trials showing survival benefit in heart failure. The common sequence is tartrate first, then a switch once the dose is settled.

Sometimes, and it should be arranged in advance rather than improvised. Keeping a few short-acting tartrate tablets for the predictable episodes, such as nebulizer treatments, acute illness, or colonoscopy prep, is a deliberate strategy for people whose resting heart rate leaves enough margin. Check your pulse before taking one rather than dosing off the sensation, and agree on the threshold and the maximum with your physician first.

Often, with attention. Metoprolol is beta-1 selective, acting mainly on the heart rather than the airways, which is why it is used in many people with asthma when a non-selective beta blocker would not be considered. The selectivity is relative and decreases at higher doses, so the decision depends on your dose and how well your asthma is controlled, and any change in breathing after a dose increase should be reported.

Deep-Dive Questions

The trials that established mortality and hospitalization benefit for beta blockade in heart failure, most notably MERIT-HF, used the extended-release succinate formulation, so the evidence base is attached to that product. The proposed mechanism for the difference is sustained receptor blockade without the trough periods an immediate-release schedule produces, since intermittent gaps in coverage may blunt the remodeling benefit. Immediate-release metoprolol controls rate effectively and simply lacks a comparable body of outcome data.

An immediate-release schedule produces higher drug levels a couple of hours after each dose and lower ones before the next. Someone whose symptoms cluster at a predictable time can find that pattern either helpful or frustrating depending on alignment. It also means side effects such as fatigue or lightheadedness concentrate near the peak while symptom breakthrough concentrates near the trough, which is why a person switching to steady release sometimes reports both effects softening at once.

Beta-1 receptors are concentrated in cardiac tissue and beta-2 receptors in airway smooth muscle, and metoprolol binds beta-1 with substantially higher affinity. Receptor binding is a matter of concentration rather than an absolute switch, so as the dose rises and drug levels climb, meaningful occupancy of beta-2 receptors begins. This is why a low dose is frequently tolerated in asthma while a higher one provokes bronchospasm in the same person.

Metoprolol is metabolized primarily by the CYP2D6 enzyme, so drugs that inhibit it raise metoprolol concentrations substantially. Fluoxetine, paroxetine, and bupropion are common examples, and the interaction can turn a well-tolerated dose into one producing bradycardia and fatigue. Genetic variation adds to this, since poor metabolizers carry higher levels at any given dose, which is one explanation for people who cannot tolerate doses others handle easily.

Ready when you are